Incidence and predictors of drug-eluting stent fractures in long coronary disease

International Journal of Cardiology

Volumn 133, Issue 3, 2009, Pages 354-358

  Kim, Hyun Sook ^a   Kim, Young Hak ^b   Lee, Seung Whan ^b   Park, Duk Woo ^b   Lee, Cheol Whan ^b   Hong, Myeong Ki ^b   Park, Seong Wook ^b   Ko, Jae Ki ^c   Park, Jae Hyeong ^d   Lee, Jae Hwan ^d   Choi, Si Wan ^d   Seong, In Whan ^d   Cho, Yoon Haeng ^e   Lee, Nae Hee ^e   Kim, June Hong ^f   Chun, Kook Jin ^f   Park, Seung Jung ^b  

^a Hallym University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

^d Chungnam National University   (South Korea)

^e Soonchunhyang University College of Medicine   (South Korea)

^f Pusan National University School of Medicine   (South Korea)

Author keywords

Coronary artery disease; Drug eluting stent; Stent fracture

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTHESIS FAILURE; RIGHT CORONARY ARTERY; STENT FRACTURE; AGED; COMPARATIVE STUDY; CORONARY DISEASE; MIDDLE AGED; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY;

ADULT; AGED; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES;

EID: 63149164938     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.01.005     Document Type: Article

References (12)

1. Aoki J., Nakazawa G., Tanabe K., et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv 69 (2007) 380-386
2. Lee M.S., Jurewitz D., Aragon J., Forrester J., Makkar R.R., and Kar S. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cardiovasc Interv 69 (2007) 387-394
3. Park J.S., Shin D.G., and Kim Y.J. Fractured DES with a patent coronary artery: clinical implications. J Invasive Cardiol 19 (2007) E43-E45
4. Shite J., Matsumoto D., and Yokoyama M. Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur Heart J 27 (2006) 1389
5. Sianos G., Hofma S., Ligthart J.M., et al. Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv 61 (2004) 111-116
6. Hamilos M.I., Papafaklis M.I., Ligthart J.M., Serruys P.W., and Sianos G. Stent fracture and restenosis of a paclitaxel-eluting stent. Hellenic J Cardiol 46 (2005) 439-442
7. Kim Y.H., Park S.W., Lee S.W., et al. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation 114 (2006) 2148-2153
8. Ellis S.G., Vandormael M.G., Cowley M.J., et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation 82 (1990) 1193-1202
9. Scheinert D., Scheinert S., Sax J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005) 312-315
10. Marrey R.V., Burgermeister R., Grishaber R.B., and Ritchie R.O. Fatigue and life prediction for cobalt-chromium stents: a fracture mechanics analysis. Biomaterials 27 (2006) 1988-2000
11. Halkin A., Carlier S., and Leon M.B. Late incomplete lesion coverage following Cypher stent deployment for diffuse right coronary artery stenosis. Heart 90 (2004) e45
12. Min P.K., Yoon Y.W., and Moon Kwon H. Delayed strut fracture of sirolimus-eluting stent: a significant problem or an occasional observation?. Int J Cardiol 106 (2006) 404-406